Innovative Service Delivery for Secondary Prevention of PTSD
Innovative Service Delivery for Secondary Prevention of PTSD in At-Risk OIF-OEF Service Men and Women
調査の概要
詳細な説明
OIF and OEF service men and women exposed to high levels of violence are at risk for developing mental health disorders including Post-traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD). Even those with less severe symptoms who fail to meet diagnostic criteria for a mental health disorder may struggle to return to pre-deployment functioning. Studies suggest that a significant percentage of veterans may suffer from "subthreshold" PTSD; although their symptom presentation is less severe, these veterans experience emotional distress and reduced quality of life.
Given that Veterans Affairs (VA) mental-health service providers are faced with the important and challenging task of alleviating the emotional suffering of our service men and women while staying within budget confines, we need effective, practical, evidence-based treatments that can be delivered in an expedient and cost-effective manner. Thus, the current project has two primary objectives: 1) to develop, implement, and evaluate a treatment program (Behavioral Activation and Therapeutic Exposure, BATE) for OIF and OEF veterans with PTSD symptoms, and 2) to determine whether or not this program delivered via telepsychology will be as effective as in-person treatment. Secondary objectives include determining: 1) which treatment modality is more effective in terms of process variables (e.g., treatment satisfaction, session attendance), 2) which treatment modality is more cost-effective, and 3) whether treatment effects differ across race and gender. Study participants will be randomized to two treatment conditions, BATE delivered via telepsychology (BATE-T) and BATE delivered in-person (BATE-IP).
The current treatment protocol is based on two, research-supported therapeutic rationales, Behavioral Activation (BA) and Therapeutic Exposure (TE). Briefly, the treatment aims to increase the participant's engagement in healthy activities (i.e., activities that are naturally reinforcing and promote the participant's life values) and exposure activities (i.e., activities that target specific PTSD symptoms such as avoidance and hyperarousal). Treatment will be implemented in eight, one and half hour sessions. Although research supports the effectiveness of behavior- and exposure-based treatments for trauma-related mental health problems, a potential risk for any counseling program that targets avoidance symptoms is a temporary increase in emotional distress. Therapists will inform participants that this is a normal "side effect" of treatment. However, over the course of treatment should a participant's emotional distress rise to a level above what can be handled via outpatient counseling, the participant will be removed from the study and appropriate referrals will be made.
The anticipated duration of this study is four years. Based on results of the study, we will finalize the treatment manual. In terms of clinical applicability, we plan to present study findings at conferences and disseminate the treatment manual to VA mental health service providers in approximately four to five years. Study findings will address important gaps in the PTSD literature, yielding several contributions to the field. First, to the extent that BATE effectively reduces symptom severity, this investigational treatment may benefit individual OIF/OEF service men and women by alleviating emotional suffering and improving quality of life. Second, to the extent that BATE prevents the development of full-blown PTSD in subclinical military personnel, this investigational treatment may reduce attrition from the military due to untreated mental health problems. Third, only a small percentage of those who might benefit from counseling actually seek services due to barriers associated with traditional service delivery practices such as geographic distance from the VA hospital and stigma of psychological treatment. Thus, as telemedicine has been shown to circumvent these barriers to care, the current project has the potential to reach an otherwise underserved population: subclinical OIF and OEF service men and women who may be reluctant to seek care. Fourth, to the extent that BATE-T produces results comparable to BATE-IP, this study may potentially identify a cost-effective alternative to in-person treatment thereby reducing post-service treatment costs to VA's.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、29403
- Medical University of South Carolina
-
Charleston、South Carolina、アメリカ、29403
- Ralph H. Johnson VAMC
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Participants will be OIF/OEF military personnel,
- age 21 and above, and
- with symptoms of posttraumatic stress disorder (PTSD) assigned on the basis of the Clinician Administered PTSD Scale (CAPS) and PTSD Checklist-Military (PCL-M).
Exclusion Criteria:
- Actively psychotic or demented persons,
- individuals with both suicidal ideation and clear intent, and
- individuals meeting criteria for substance dependence will be excluded from participation.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:BATE-T
Behavioral Activation Therapeutic Exposure done while the patient is at home via videoconferencing technology
|
This intervention combines Behavior Activation Therapy and Exposure Therapy to treat PTSD symptoms.
|
アクティブコンパレータ:BATE-IP
Behavioral Activation Therapeutic Exposure done in the therapist's office
|
This intervention combines Behavior Activation Therapy and Exposure Therapy to treat PTSD symptoms.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
The major objective of this study is to determine if Behavioral Activation with Therapeutic Exposure (BATE) delivered via Telemedicine is as effective as BATE In Person.
時間枠:1 year
|
This is measured in terms of (1) clinical (PTSD and Depression); (2) process (Treatment Satisfaction and Attrition); and (3) economic (Cost) outcomes.
|
1 year
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
ベックうつ病インベントリ-II (BDI-II)
時間枠:ベースライン
|
ベースライン
|
|
ベックうつ病インベントリ-II (BDI-II)
時間枠:3ヶ月
|
3ヶ月
|
|
臨床医管理 PTSD スケール (CAPS)
時間枠:8週間
|
8週間
|
|
Clinician Administered PTSD Scale (CAPS)
時間枠:Baseline
|
Baseline
|
|
Clinician Administered PTSD Scale (CAPS)
時間枠:3 months
|
3 months
|
|
Clinician Administered PTSD Scale (CAPS)
時間枠:1 year
|
1 year
|
|
The Deployment Risk and Resiliency Inventory (DRRI)
時間枠:Baseline
|
Baseline
|
|
PTSD Checklist-Military (PCL-M)
時間枠:Baseline
|
Baseline
|
|
PTSD Checklist-Military (PCL-M)
時間枠:4 weeks
|
4 weeks
|
|
PTSD Checklist-Military (PCL-M)
時間枠:8 weeks
|
8 weeks
|
|
PTSD Checklist-Military (PCL-M)
時間枠:3 months
|
3 months
|
|
PTSD Checklist-Military (PCL-M)
時間枠:1 year
|
1 year
|
|
Beck Depression Inventory-II (BDI-II)
時間枠:4 weeks
|
4 weeks
|
|
Beck Depression Inventory-II (BDI-II)
時間枠:8 weeks
|
8 weeks
|
|
Beck Depression Inventory-II (BDI-II)
時間枠:1 year
|
1 year
|
|
Health Related Functioning: Medical Outcome Study Short Study Forms-36 Health Survey (SF 36)
時間枠:Baseline
|
Baseline
|
|
Health Related Functioning: Medical Outcome Study Short Study Forms-36 Health Survey (SF 36)
時間枠:4 weeks
|
4 weeks
|
|
Health Related Functioning: Medical Outcome Study Short Study Forms-36 Health Survey (SF 36)
時間枠:8 weeks
|
8 weeks
|
|
Health Related Functioning: Medical Outcome Study Short Study Forms-36 Health Survey (SF 36)
時間枠:3 months
|
3 months
|
|
Health Related Functioning: Medical Outcome Study Short Study Forms-36 Health Survey (SF 36)
時間枠:1 year
|
1 year
|
|
Charleston Psychiatric Outpatient Satisfaction Scale (CPOSS-VA)
時間枠:8 weeks
|
8 weeks
|
|
Service Delivery Perceptions Questionnaire
時間枠:8 weeks
|
8 weeks
|
|
Prior Experience with Computer and Audiovisual Technology
時間枠:Baseline
|
Short measure to learn more about participants' prior experience and comfort level with computers and audiovisual technology
|
Baseline
|
協力者と研究者
捜査官
- 主任研究者:Ronald Acierno, PhD、VA Office of Research and Development
出版物と役立つリンク
一般刊行物
- Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif. 2011 Mar;35(2):111-61. doi: 10.1177/0145445510390929.
- Acierno R, Rheingold A, Amstadter A, Kurent J, Amella E, Resnick H, Muzzy W, Lejuez C. Behavioral activation and therapeutic exposure for bereavement in older adults. Am J Hosp Palliat Care. 2012 Feb;29(1):13-25. doi: 10.1177/1049909111411471. Epub 2011 Jun 17.
- Gros DF, Price M, Yuen EK, Acierno R. Predictors of completion of exposure therapy in OEF/OIF veterans with posttraumatic stress disorder. Depress Anxiety. 2013 Nov;30(11):1107-13. doi: 10.1002/da.22207. Epub 2013 Oct 21.
- Gros DF, Price M, Strachan M, Yuen EK, Milanak ME, Acierno R. Behavioral activation and therapeutic exposure: an investigation of relative symptom changes in PTSD and depression during the course of integrated behavioral activation, situational exposure, and imaginal exposure techniques. Behav Modif. 2012 Jul;36(4):580-99. doi: 10.1177/0145445512448097. Epub 2012 Jun 7.
- Gros DF, Strachan M, Ruggiero KJ, Knapp RG, Frueh BC, Egede LE, Lejuez CW, Tuerk PW, Acierno R. Innovative service delivery for secondary prevention of PTSD in at-risk OIF-OEF service men and women. Contemp Clin Trials. 2011 Jan;32(1):122-8. doi: 10.1016/j.cct.2010.10.003. Epub 2010 Oct 14.
- Gros DF, Veronee K, Strachan M, Ruggiero KJ, Acierno R. Managing suicidality in home-based telehealth. J Telemed Telecare. 2011;17(6):332-5. doi: 10.1258/jtt.2011.101207. Epub 2011 Aug 15.
- Price M, Gros DF, Strachan M, Ruggiero KJ, Acierno R. Combat experiences, pre-deployment training, and outcome of exposure therapy for post-traumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom veterans. Clin Psychol Psychother. 2013 Jul-Aug;20(4):277-85. doi: 10.1002/cpp.1768. Epub 2012 Jan 18.
- Price M, Gros DF, Strachan M, Ruggiero KJ, Acierno R. The Role of Social Support in Exposure Therapy for Operation Iraqi Freedom/Operation Enduring Freedom Veterans: A Preliminary Investigation. Psychol Trauma. 2013 Jan 1;5(1):93-100. doi: 10.1037/a0026244.
- Strachan M, Gros DF, Ruggiero KJ, Lejuez CW, Acierno R. An integrated approach to delivering exposure-based treatment for symptoms of PTSD and depression in OIF/OEF veterans: preliminary findings. Behav Ther. 2012 Sep;43(3):560-9. doi: 10.1016/j.beth.2011.03.003. Epub 2011 May 24.
- Strachan M, Gros DF, Yuen E, Ruggiero KJ, Foa EB, Acierno R. Home-based telehealth to deliver evidence-based psychotherapy in veterans with PTSD. Contemp Clin Trials. 2012 Mar;33(2):402-9. doi: 10.1016/j.cct.2011.11.007. Epub 2011 Nov 11.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
PTSDの臨床試験
-
Imperial College Healthcare NHS TrustImperial College London募集
-
VA Office of Research and DevelopmentUniversity of California, San Diego募集
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)積極的、募集していない
-
Oregon Health and Science University招待による登録
-
VA Office of Research and DevelopmentPortland VA Medical Center積極的、募集していない
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare System完了
Behavioral Activation Therapeutic Exposure (BATE)の臨床試験
-
University of Maryland, College ParkUniversity of Maryland, Baltimore; Henry Ford Health System募集物質関連障害 | オピオイド使用障害 | 治療遵守 | オピオイドの使用 | ケアの保持 | オピオイド中毒 | オピオイド投薬支援治療アメリカ
-
University of Maryland, College ParkUniversity of Maryland, Baltimore; National Center for Complementary and Integrative Health...完了物質使用 | 物質使用障害 | オピオイド使用障害 | ケアの保持 | メタドン治療 | ピア配信 | オピオイド使用障害(MOUD)の投薬 | 行動活性化アメリカ